en sv

Articles


Every day, progress is made in the stem cell revolution. We will do our best to keep you informed here on the site.

Cellaviva Sverige October 20, 2020
Allogeneic cell therapy has once again shown efficacy in type 1 diabetes

Allogeneic cell therapy has once again shown efficacy in type 1 diabetes

“Our vision is to improve treatment options for thousands, maybe millions of patients and reducing healthcare costs with the aid of stem cell therapy.” Mathias Svahn, CEO of Cellaviva and NextCell Pharma.

Cellaviva Sverige September 8, 2020
ProTrans shows significant effect in Diabetes

ProTrans shows significant effect in Diabetes

Cellaviva's parent company NextCell Pharma AB ("NextCell") today announces that the ProTrans-2 clinical trial met the primary endpoint. Patients treated with a single dose ProTrans show a statistically significant improved...

Cellaviva Sverige June 8, 2020
Type 1 diabetes treatment with umbilical cord stem cells

Type 1 diabetes treatment with umbilical cord stem cells

NextCell expects ProTrans to be an effective treatment for autoimmune diseases NextCell expects ProTrans to be an effective treatment for autoimmune diseases, other inflammatory conditions and in transplant reactions following...

Cellaviva Sverige June 5, 2020
Crown Princess Victoria awards research prize to Cellaviva's Principal investigator

Crown Princess Victoria awards research prize to Cellaviva's Principal investigator

Cellaviva and NextCell Pharma's Principal investigator receive the award as Child Diabetes Researcher of the Year by Swedish Crown Princess Victoria. Cellaviva's Principal investigator for both our clinical studies with...

Cellaviva Sverige May 11, 2020
Covid-19 study shows the positive effect of treatment with stem cells

Covid-19 study shows the positive effect of treatment with stem cells

First studies testing the effect of mesenchymal stem cells in the treatment of COVID-19 have been published. In this contex, Dr. Leng and colleagues found that a single injection had an effect on 7 patients with COVID-19.

Cellaviva Sverige April 23, 2020
Covid-19 patients are treated with stem cells

Covid-19 patients are treated with stem cells

The Corona virus enters the host cell by binding to a receptor on the cells in the blood vessels. The body then responds as soon as the immune system recognizes that there are invaders and sends a number of different cell types and antibodies to try to destroy the virus. The result is a battlefield in every organ affected by the virus, between our immune system and the virus. In the case of COVID-19, the intensity of the battle can trigger a devastating immune reaction.

Load MoreLoading

Can stem cells treat type 1 diabetes? Are stem cell transplants performed today? We keep you updated on news, as well as the latest developments in stem cell research. Our goal is for everyone in Sweden to be informed about the possibility of saving stem cells from the umbilical cord at birth. Our articles therefore focus on how this can be a unique investment for the future.

Focusing on stem cell research

Nextcell Pharma, a part of Cellaviva, researches daily to develop new cell therapies. We therefore share our own articles, news and articles on research from the rest of the world on stem cell treatment.